Developing New Platforms and Workflows to Support Diversity in Drug Modalities
Join us for an exciting talk on the increasing diversity of therapeutic modalities driven by new insights into biological systems. Dave Madge will explore emerging target classes such as protein–protein and protein–nucleic acid interactions, which require novel strategies that combine the stability and cell penetration of small molecules with the selectivity and potency of biologics. The presentation will also highlight how evolving design, synthesis, and testing approaches—as well as new platforms and screening cascades—are enabling these opportunities to be realized.
register now
